{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Insufficient number of testing kits leading to infeasibility of large-scale COVID-19 testing.\",\"Impact\":\"Delayed identification and isolation of infected individuals, leading to increased transmission and spread of the virus.\",\"Mitigation\":\"Increase production and distribution of testing kits, prioritize testing for high-risk individuals, develop alternative testing methods such as rapid antigen tests.\",\"Technologies\":\"Rapid antigen tests, automation of testing processes, AI-powered diagnostic tools.\",\"People\":\"General population, healthcare workers, individuals at high risk of severe illness from COVID-19.\",\"Owner\":\"Health organizations, governments, manufacturers of testing kits.\"},{\"Description\":\"Inability to distinguish COVID-19 symptoms from common flu, leading to challenges in determining testing criteria.\",\"Impact\":\"Delayed or missed diagnosis of COVID-19 cases, resulting in unchecked spread of the virus and difficulty in containment efforts.\",\"Mitigation\":\"Public education on COVID-19 symptoms, development of symptom-based screening tools, research on unique COVID-19 symptoms, prioritization of high-risk groups for testing.\",\"Technologies\":\"Symptom-based screening tools, AI-powered diagnostic tools, telemedicine for remote symptom assessment.\",\"People\":\"General population, healthcare workers, public health officials.\",\"Owner\":\"Health organizations, governments, public health agencies.\"}]}"}}